BIQOVIZ Trademark

Trademark Overview


On Monday, August 3, 2020, a trademark application was filed for BIQOVIZ with the United States Patent and Trademark Office. The USPTO has given the BIQOVIZ trademark a serial number of 90089032. The federal status of this trademark filing is ABANDONED - EXPRESS AFTER PUB as of Monday, May 10, 2021. This trademark is owned by Regeneron Pharmaceuticals, Inc.. The BIQOVIZ trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for treatment or prevention of COVID-19, coronavirus disease, and respiratory diseases and disorders; antivirals for treatment or prevention of COVID-19, coronavirus disease, and respiratory diseases and disorders
biqoviz

General Information


Serial Number90089032
Word MarkBIQOVIZ
Filing DateMonday, August 3, 2020
Status605 - ABANDONED - EXPRESS AFTER PUB
Status DateMonday, May 10, 2021
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 30, 2021

Trademark Statements


Goods and ServicesPharmaceutical preparations for treatment or prevention of COVID-19, coronavirus disease, and respiratory diseases and disorders; antivirals for treatment or prevention of COVID-19, coronavirus disease, and respiratory diseases and disorders

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code8 - Abandoned
Class Status DateMonday, May 10, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameRegeneron Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressTarrytown, NY 10591

Party NameRegeneron Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressTarrytown, NY 10591

Trademark Events


Event DateEvent Description
Monday, May 10, 2021ABANDONMENT NOTICE E-MAILED - AFTER PUBLICATION
Monday, May 10, 2021ABANDONMENT - AFTER PUBLICATION
Wednesday, May 5, 2021TEAS EXPRESS ABANDONMENT RECEIVED
Tuesday, April 27, 2021EXTENSION OF TIME TO OPPOSE RECEIVED
Tuesday, March 30, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 30, 2021PUBLISHED FOR OPPOSITION
Wednesday, March 10, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Saturday, February 20, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, February 10, 2021ASSIGNED TO EXAMINER
Tuesday, September 1, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, August 6, 2020NEW APPLICATION ENTERED IN TRAM